about
Interleukin-17 inhibitors. A new era in treatment of psoriasis and other skin diseasesPathogenic Inflammation and Its Therapeutic Targeting in Systemic Lupus ErythematosusAssociation between mean platelet volume and disease severity in patients with psoriasis and psoriatic arthritis.Cytokine-modulating strategies and newer cytokine targets for arthritis therapy.Efficacy and safety of secukinumab in the treatment of moderate to severe plaque psoriasis: a meta-analysis of randomized controlled trialsInhibition of RORγt activity and Th17 differentiation by a set of novel compounds.Prevalence of cardiovascular disease risk factors, and metabolic syndrome and its components in patients with psoriasis aged 30 to 49 yearsAutoimmunogenicity during anti-TNF therapy in patients with psoriasis and psoriatic arthritisInterferon Tau Affects Mouse Intestinal Microbiota and Expression of IL-17.IL-23 plasma level is strongly associated with CMV status and reactivation of CMV in renal transplant recipients.Carotid Catheterization and Automated Blood Sampling Induce Systemic IL-6 Secretion and Local Tissue Damage and Inflammation in the Heart, Kidneys, Liver and Salivary Glands in NMRI Mice.Broad-spectrum Antibiotic Plus Metronidazole May Not Prevent the Deterioration of Necrotizing Enterocolitis From Stage II to III in Full-term and Near-term Infants: A Propensity Score-matched Cohort Study.Genome-Wide Immune Modulation of TLR3-Mediated Inflammation in Intestinal Epithelial Cells Differs between Single and Multi-Strain Probiotic CombinationElevated Circulating Interleukin 33 Levels in Stable Renal Transplant Recipients at High Risk for Cardiovascular Events.Serum IL-17A in Behçet's disease.Human Memory CD4+ T Cell Immune Responses against Giardia lamblia.Interleukin-17A Gene Variability in Patients with Type 1 Diabetes Mellitus and Chronic Periodontitis: Its Correlation with IL-17 Levels and the Occurrence of Periodontopathic Bacteria.Clinical characteristics of cutaneous lupus erythematosus.Evaluation of serum concentrations of the selected cytokines in patients with localized scleroderma.Fish gut-liver immunity during homeostasis or inflammation revealed by integrative transcriptome and proteome studies.Increased Interleukin-17F is Associated with Elevated Autoantibody Levels and More Clinically Relevant Than Interleukin-17A in Primary Sjögren's Syndrome.Major involvement of bacterial components in rheumatoid arthritis and its accompanying oxidative stress, systemic inflammation and hypercoagulability.T Cells in Osteoarthritis: Alterations and Beyond.Amino-acid transporters in T-cell activation and differentiation.Halofuginone - the multifaceted molecule.IL-17A-producing CD8(+)T cells as therapeutic targets in autoimmunity.Monoclonal antibody therapy in multiple sclerosis: critical appraisal and new perspectives.Genetic background of skin barrier dysfunction in the pathogenesis of psoriasis vulgaris.T and NK Cell Phenotypic Abnormalities in Systemic Sclerosis: a Cohort Study and a Comprehensive Literature Review.Pituitary tumor transforming gene PTTG2 induces psoriasis by regulating vimentin and E-cadherin expression.Evidence for the association of Hashimoto's thyroiditis with psoriasis: a cross-sectional retrospective study.Melatonin signaling in T cells: Functions and applications.Cytokine profiles in axial spondyloarthritis.Expression of IL-17A, E, and F and their receptors in human prostatic cancer: Comparison with benign prostatic hyperplasia.Association between IL17A and IL17F polymorphisms and risk of Henoch-Schonlein purpura in Chinese children.Impact of nicotine on the interplay between human periodontal ligament cells and CD4+ T cells.Intranasal immunization with heat shock protein 60 induces CD4(+) CD25(+) GARP(+) and type 1 regulatory T cells and inhibits early atherosclerosis.Cathepsin S Is Involved in Th17 Differentiation Through the Upregulation of IL-6 by Activating PAR-2 after Systemic Exposure to Lipopolysaccharide from Porphyromonas gingivalis.Therapeutic Effect of Exogenous Truncated IK Protein in Inflammatory Arthritis.mTOR Mediates IL-23 Induction of Neutrophil IL-17 and IL-22 Production.
P2860
Q28069350-97BF160F-4A5E-4998-804F-BBFAF137CF50Q28088753-072138A4-2018-4BDE-8138-E93E8EDC8C24Q33645857-0658D6A5-7351-4521-AB80-75854294A2F2Q34456715-7D492622-9ABB-4836-A7DC-CD9DEBE7EE2EQ35643453-2E6114C9-1BAE-4FE0-9D40-BACB2BF58382Q35645390-34614F5A-F20E-4B1F-9140-3CF721EB46E1Q36048427-47BE545F-A87F-4542-9032-FF441640EE18Q36048476-26B18E7A-3730-4C8F-98D5-AAC74CD83D69Q36127624-C1753C11-6AF1-4189-A7C8-6B4E24B56026Q36156499-89683C64-3F2D-47FC-AF2D-7821E6187DB3Q36188797-A5C0C749-4275-45FD-B923-457EFEDBF771Q36207182-9CF1259E-4FF6-44FA-BE65-8C16CCF709B5Q36252576-1057AE4E-9576-440F-9912-6292C9B3569FQ36257484-23686D4B-7883-4528-BEC9-205D85529DA7Q36408499-8F4088E9-9D06-4CF4-A02B-3D84186E97F4Q36457634-1CF53450-0A60-4768-AE55-F0EB73B7484BQ36564664-7ACF32C5-160F-406A-9962-817F92176723Q36690483-AB311211-03F6-4246-BF1B-544AF5DD5CE0Q36690499-283E7243-9667-4360-B25C-95E4CF572EE0Q37390449-2084ECD2-5DF6-4DAE-93B3-D74353D2A3FDQ37624932-F3D271F1-FB5D-4537-B621-7779FD6C6CBCQ37632332-F80D0F8A-48DD-4ABC-9714-6CB0E18E5809Q37727495-3C1D9734-E6A7-402D-86CA-B988C6CCFAF9Q37745334-B204D8EF-C19A-4DF5-90F8-197D7C27F9BCQ38311322-8A2DE3A3-05E6-4C45-B2B4-05B34F8BB18EQ38328539-5CEF2819-0B6F-4ACA-BEF6-9B2EC8B031BFQ38364547-3B69FB9F-69DE-473A-8E7F-46B7F590BC5AQ38504119-441AF50E-F21C-4291-9B3B-36FE2EBD722FQ38601631-A2ED55F0-7BB5-4095-9FCF-B5D988A981ADQ38815834-41E65C0B-3269-4360-B253-213A665AE87AQ38952171-E0B55CF5-C6B4-47EA-89B9-92A1E0058319Q39115619-2E6A2BD0-D551-4DEE-A602-D459D641B53AQ39608151-75CFDAF0-1B18-4A14-9509-DF029F3556DEQ40555072-2E1F0323-90A1-41A4-8ED1-28C4C2DF3854Q40829941-6B587B79-1656-4881-B75B-71236EDE3219Q40916314-EB8C47FD-74B7-4D88-970D-CC343C93FD15Q40959589-4CBDF076-5111-48BC-8BA3-A086057B063DQ41024037-C9E6B228-8F1C-438E-81CB-7CC7FAAA5E56Q41660538-EDAFBB63-87AE-4BF4-A279-6CC9A99CE793Q42784399-B3973552-1E2B-4D02-B22E-0FEDE3D9BC6E
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Interleukin-17 in human inflammatory diseases.
@en
type
label
Interleukin-17 in human inflammatory diseases.
@en
prefLabel
Interleukin-17 in human inflammatory diseases.
@en
P2093
P2860
P356
P1476
Interleukin-17 in human inflammatory diseases.
@en
P2093
Arezoo Gowhari Shabgah
Ebrahim Fattahi
Fatemeh Zare Shahneh
P2860
P304
P356
10.5114/PDIA.2014.40954
P577
2014-08-01T00:00:00Z